Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor’s cellular immunotherapy products: the MDR-105-SAE

Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor’s cellular immunotherapy products: the MDR-105-SAE

Abstract Background Immunosuppression in transplantation continues to be associated with a multitude of adverse effects. Induction of immune tolerance may be a viable strategy to reduce dependence on immunosuppression. Various trials are currently underway to assess the efficacy of this strategy. Ho...

Full description

Bibliographic Details
Main Authors: Sam Kant, Dixon B. Kaufman, Lenuta Micsa, Daniel C. Brennan
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Trials
Subjects:
Tolerance
Kidney transplantation
Immunotherapy
Immunosuppression
Online Access:https://doi.org/10.1186/s13063-023-07204-4

Similar Items

Similar Items